Entia Biosciences, Inc.

OTCPK:ERGO Stock Report

Market Cap: US$3.4k

Entia Biosciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Timothy Timmins

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.6yrs
CEO ownershipn/a
Management average tenure8.7yrs
Board average tenureno data

Recent management updates

No updates

Recent updates

No updates


CEO

Timothy Timmins (67 yo)

6.6yrs

Tenure

US$141,524

Compensation

Mr. Timothy A. Timmins has been the Chief Executive Officer and President of Entia Biosciences, Inc. since November 28, 2017. He serves as President and Director at BioModeling Solutions, LLC. Mr. Timmins...


Leadership Team

NamePositionTenureCompensationOwnership
Marvin Hausman
Chairman and Chief Science & Technology Officer15.8yrsUS$174.00kno data
Timothy Timmins
CEO & President6.6yrsUS$141.52kno data
Elliot A. Shelton
Secretary and Director13.7yrsno datano data

8.7yrs

Average Tenure

74yo

Average Age

Experienced Management: ERGO's management team is seasoned and experienced (8.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.